US EditionPublished • loading... • Updated
Madhya Pradesh cough syrup deaths: PIL filed in Supreme Court, seeks CBI probe
The petition demands a judicial inquiry, nationwide testing, compensation, and regulatory reforms following 16 child deaths linked to toxic cough syrups, with bans already in place in several states.
- On October 7, 2025, advocate Vishal Tiwari submitted a Public Interest Litigation to the Supreme Court, requesting an independent probe into the deaths of 14 children in Madhya Pradesh, which have been linked to the suspected use of tainted cough syrup.
- The petition followed reports from August that children in Chhindwara, Madhya Pradesh, developed fatal kidney symptoms after consuming cough syrups such as Coldrif, with deaths later confirmed in Rajasthan as well.
- Authorities arrested a senior paediatrician for alleged negligence, booked the manufacturer Sresan Pharmaceuticals under strict legal provisions, formed a special investigation team, and banned Coldrif in several states.
- Regulatory reports found Refile Syrup with 0.616% and Respifresh TR with 1.342% DEG/EG, far exceeding the permissible 0.1% limit, and the PIL requested compensation and a wider review of drug safety.
- The case highlights calls for urgent reforms, as the Indian Medical Association and petitioners argued repeated regulatory failures have put children's lives at risk and demanded nationwide testing and improved oversight.
Insights by Ground AI
17 Articles
17 Articles
The entire country is outraged by the deaths of children after consuming cough syrup, and now, the discovery of a dangerous chemical in a cold syrup manufactured in Tamil Nadu has caused a stir. Similar cases have been reported before. Let's explain what diethylene glycol is and how dangerous it is.
Cough Syrup Deaths: PIL In SC Blames Regulatory Lapses, Seeks Ban On Contaminated Syrups
A PIL has been filed in the Supreme Court following the deadly cough syrup tragedy, seeking a court-monitored expert panel, nationwide recall, compensation for families, and accountability for regulatory failures.
·India
Read Full ArticleCoverage Details
Total News Sources17
Leaning Left2Leaning Right6Center1Last UpdatedBias Distribution67% Right
Bias Distribution
- 67% of the sources lean Right
67% Right
L 22%
11%
R 67%
Factuality
To view factuality data please Upgrade to Premium
